Literature DB >> 29457280

Continuous blood purification ameliorates clinical signs and corrects the plasma phospholipid levels of patients with multiple organ dysfunction syndromes.

Wei Wen1, Kun Wang2, Zhi-Ming Jiang1, Zhong-Hui Zhang1, Lei Zhou1.   

Abstract

BACKGROUND: Multiple organ dysfunction syndromes (MODS) is reported as a leading cause of mortality in intensive care units. Recently, continuous blood purification (CBP) has been mostly applied for MODS treatment. Thus, the purpose of this study was to investigate the effects of CBP on plasma phospholipid level in patients with MODS.
METHODS: A total of 126 patients with MODS and 120 healthy people were collected. The serum cytokine levels, blood biochemical parameters, and blood gas indexes were detected, and the correlation among phospholipid compounds with serum cytokine levels, blood biochemical parameters, and blood gas indexes was analyzed.
RESULTS: Before CBP, levels of body temperature, RR, HR, CVP, IL-6, IL-10, TNF-α, BUN, SCr, PaCO2 , SM747, and LPC540 were obviously higher, and pH, HCO3- , PaO2 , SaO2 , PE750, PI885, PC792, PC826, PC830, PC854, PC802, and PG747 were lower in the MODS group than those in the control group. During CBP, the MODS group had gradually declined RR, CVP, levels of IL-6, IL-10 and TNF-α, BUN, SCr, PaCO2 , SM747, and LPC540 and increased HCO3- , PaO2 and SaO2 , PE750, PI885, PC792, PC826, PC830, PC854, PC802, and PG747. Besides, levels of PE750, PI885, PC792, PC826, PC830, PC854, PC802, and PG747 had an obvious negative correlation with levels of TNF-α, IL-10, IL-6, BUN, SCr, and PaCO2 , and a significant positive correlation with levels of HCO3- , PaO2 , and SaO2 .
CONCLUSION: CBP could effectively ameliorate clinical signs of patients with MODS and correct the plasma phospholipid levels.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  CBP; Multiple organ dysfunction syndromes; Plasma phospholipid levels; Serum cytokines

Year:  2018        PMID: 29457280      PMCID: PMC6816832          DOI: 10.1002/jcla.22411

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  42 in total

1.  Reducing elevated heart rate in patients with multiple organ dysfunction syndrome by the I (f) (funny channel current) inhibitor ivabradine : MODI (f)Y trial.

Authors:  Sebastian Nuding; Henning Ebelt; Robert S Hoke; Annette Krummenerl; Andreas Wienke; Ursula Müller-Werdan; Karl Werdan
Journal:  Clin Res Cardiol       Date:  2011-06-03       Impact factor: 5.460

2.  Treatment of multiple organ failure through sepsis by surgery and blood purification.

Authors:  Yoshihiro Asanuma; Tsutomu Sato; Hitoshi Kotanagi; Yuzo Yamamoto; Hajime Nakae
Journal:  Ther Apher Dial       Date:  2004-06       Impact factor: 1.762

3.  After the bomb drops: a new look at radiation-induced multiple organ dysfunction syndrome (MODS).

Authors:  Jacqueline P Williams; William H McBride
Journal:  Int J Radiat Biol       Date:  2011-03-21       Impact factor: 2.694

4.  Polydatin: a new therapeutic agent against multiorgan dysfunction.

Authors:  Zhenhua Zeng; Zhongqing Chen; Tao Li; Junli Zhang; Youguang Gao; Siqi Xu; Shumin Cai; Ke-seng Zhao
Journal:  J Surg Res       Date:  2015-05-27       Impact factor: 2.192

Review 5.  Antibiotic dosing in multiple organ dysfunction syndrome.

Authors:  Marta Ulldemolins; Jason A Roberts; Jeffrey Lipman; Jordi Rello
Journal:  Chest       Date:  2011-05       Impact factor: 9.410

6.  [Continuous blood purification therapy in 22 children with sepsis].

Authors:  Guo-ping Lu; Zhu-jin Lu; Ling-en Zhang; Jun He; Jing Hu; Fang Wu
Journal:  Zhonghua Er Ke Za Zhi       Date:  2006-08

Review 7.  Multiple organ dysfunction syndrome in critical surgical illness.

Authors:  Philip S Barie; Lynn J Hydo; Fredric M Pieracci; Jian Shou; Soumitra R Eachempati
Journal:  Surg Infect (Larchmt)       Date:  2009-10       Impact factor: 2.150

Review 8.  A systematic review of experimental treatments for mitochondrial dysfunction in sepsis and multiple organ dysfunction syndrome.

Authors:  Anna J Dare; Anthony R J Phillips; Anthony J R Hickey; Anubhav Mittal; Benjamin Loveday; Nichola Thompson; John A Windsor
Journal:  Free Radic Biol Med       Date:  2009-08-26       Impact factor: 7.376

9.  Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease.

Authors:  Axel Schlitt; Stefan Blankenberg; Daoguang Yan; Hans von Gizycki; Michael Buerke; Karl Werdan; Christoph Bickel; Karl J Lackner; Juergen Meyer; Hans J Rupprecht; Xian-Cheng Jiang
Journal:  Nutr Metab (Lond)       Date:  2006-01-05       Impact factor: 4.169

10.  Protective effect of phosphatidylcholine on lipopolysaccharide-induced acute inflammation in multiple organ injury.

Authors:  Yoon Yang Jung; Yunsung Nam; Yong Seol Park; Ho Sung Lee; Soon Auck Hong; Beom Keun Kim; Eon Sub Park; Yoon Hee Chung; Ji Hoon Jeong
Journal:  Korean J Physiol Pharmacol       Date:  2013-06-11       Impact factor: 2.016

View more
  1 in total

1.  Continuous blood purification ameliorates clinical signs and corrects the plasma phospholipid levels of patients with multiple organ dysfunction syndromes.

Authors:  Wei Wen; Kun Wang; Zhi-Ming Jiang; Zhong-Hui Zhang; Lei Zhou
Journal:  J Clin Lab Anal       Date:  2018-02-18       Impact factor: 2.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.